Non-EU Regulator Participation IN EMA Committee Meetings Is Increasing
Non-EU countries can send their regulators to take part in EMA committee meetings even if they do not have confidentiality arrangements in place with the agency.
You may also be interested in...
The European Medicines Agency is continuing with its plans to involve non-EU regulators in scientific reviews. It notes in its 2016 activity report that Israeli regulators for the first time took part in a CHMP meeting.
Softening provisions to make EU-wide joint clinical assessments voluntary would make proposed legislation on HTA cooperation redundant, says Eurordis.
Plans for EU-wide Joint Clinical assessments will come under scrutiny at an EU council meeting next week.